Why We Led MedScout’s $5M Seed Round

Published on June 28, 2023

We are thrilled to share that we led a $5 million Seed Investment into MedScout, joined by our friends at LiveOak Venture Partners, Alumni Ventures and a16z Scout Fund. You can read MedScout’s official announcement here.

Historically, sales for medical technology and life sciences companies have been very people and live-interactions heavy. In fact, these companies spend, on average, 2-3x more on SG&A than typical technology companies. But with the pandemic forcing these companies to change the way they sell, Life science companies are now investing more into marketing and sales data. They're also leveraging tools to prioritize where to hire reps, focus them on the best opportunities, and enable them to reach out to build a pipeline.

Continue reading on website
Other news

Startups Versus Incumbents: Who Will Win the Go-to-Market AI Race?

June 22, 2023
“Who will win the go-to-market AI race?”I’ve been studying this question closely over the last 6 months. I’ve enjoyed countless debates with go-to-market leaders from the largest public companies all the way down to pre-product, pre-revenue startups with talented AI tech teams. More recently, at Stage 2 Capital, we rolled out the Go-To-Market AI Lab to understand and accelerate innovation in the e

Transforming Data Integration Infrastructure — Our Seed Investment in Versori

June 30, 2023
We’re thrilled to share that we led Versori’s $3.5M Seed round, with participation from notable angel investors including Cindy Bi of Capital X and Jamie Su, among others. You can read more in Versori’s official press release here.